Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcturus Therapeutics Holdings Inc (NQ:ARCT)

8.780 +0.060 (+0.69%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 753,685
Open 8.920
Bid (Size) 8.450 (400)
Ask (Size) 8.800 (600)
Prev. Close 8.720
Today's Range 8.550 - 9.020
52wk Range 7.930 - 24.17
Shares Outstanding 26,562,951
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Arcturus Therapeutics (NASDAQ:ARCT) Reports Mixed Q3 2025 Results, Extends Cash Runway to 2028
Arcturus Q3 2025 results show a revenue miss but a smaller-than-expected loss. The company advances its CF and OTC programs, with cash extending into 2028. 
Via Chartmill
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
From Arcturus Therapeutics Holdings Inc.
Via Business Wire

Performance

YTD
-48.6%
-48.6%
1 Month
-54.7%
-54.7%
3 Month
-22.9%
-22.9%
6 Month
-24.2%
-24.2%
1 Year
-56.9%
-56.9%

More News

Read More
Earnings Scheduled For November 10, 2025
Via Benzinga
Preview: Arcturus Therapeutics's Earnings
Via Benzinga
Arcturus Therapeutics to Attend Upcoming Investor Conferences
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
From Pomerantz LLP
Via GlobeNewswire
This Molina Healthcare Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Cathie Wood Goes Shopping: 3 Stocks She Just Bought
Via The Motley Fool
Topics ETFs
Where Arcturus Therapeutics Stands With Analysts
Via Benzinga
Arcturus' Investigational Inhaled Therapy Lacks Meaningful Lung Function Improvement, Analyst Notes Mixed Picture
Via Benzinga
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Top movers in Wednesday's session
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings
Via Benzinga
Topics Stocks
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off?
Via Stocktwits
Arcturus Crashes 55% On 'Underwhelming' Results For mRNA-Tied Cystic Fibrosis Drug
Via Investor's Business Daily
Wednesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
Via Investor Brand Network
Topics Artificial Intelligence
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
Via Benzinga
Topics Artificial Intelligence

Frequently Asked Questions

Is Arcturus Therapeutics Holdings Inc publicly traded?
Yes, Arcturus Therapeutics Holdings Inc is publicly traded.
What exchange does Arcturus Therapeutics Holdings Inc trade on?
Arcturus Therapeutics Holdings Inc trades on the Nasdaq Stock Market
What is the ticker symbol for Arcturus Therapeutics Holdings Inc?
The ticker symbol for Arcturus Therapeutics Holdings Inc is ARCT on the Nasdaq Stock Market
What is the current price of Arcturus Therapeutics Holdings Inc?
The current price of Arcturus Therapeutics Holdings Inc is 8.780
When was Arcturus Therapeutics Holdings Inc last traded?
The last trade of Arcturus Therapeutics Holdings Inc was at 11/10/25 04:00 PM ET
What is the market capitalization of Arcturus Therapeutics Holdings Inc?
The market capitalization of Arcturus Therapeutics Holdings Inc is 233.22M
How many shares of Arcturus Therapeutics Holdings Inc are outstanding?
Arcturus Therapeutics Holdings Inc has 233M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.